Artivion, Inc. (AORT) has 20 known insider and institutional holders on record. The largest holder is Mackin James P with 965,162 shares. Other notable holders include LEE DAVID ASHLEY and Davis John E.
Over the last 12 months, insiders have made 80 transactions in AORT stock — 14 buys (valued at RSU Award) and 50 sells (valued at $11.91M). Insider selling has exceeded buying during this period.
AORT Insider Ownership
Top Holder
Mackin James P
965,162 shares
Buys (12 mo)
14
$0.00 value
Sells (12 mo)
50
$11.91M value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Mackin James P |
President & CEO |
965,162 |
2026-03-04 |
|
| 2 |
Lee David Ashley |
Executive VP, COO & CFO |
348,618 |
2023-03-03 |
|
| 3 |
Davis John E |
Chief Commercial Officer |
235,367 |
2026-03-04 |
|
| 4 |
Berry Lance A |
EVP, COO, CFO & Treasurer |
217,143 |
2026-03-04 |
|
| 5 |
Holloway Jean F |
SVP, General Counsel |
197,900 |
2026-03-04 |
|
| 6 |
Capps Scott B |
VP, Clinical Research |
153,203 |
2021-03-15 |
|
| 7 |
Bevevino Daniel J |
Director |
150,061 |
2025-05-27 |
|
| 8 |
Ackerman Thomas F |
Director |
149,896 |
2025-05-27 |
|
| 9 |
Horton Amy |
VP, Chief Accounting Officer |
139,989 |
2026-03-04 |
|
| 10 |
Salveson Jon W |
Director |
129,840 |
2025-05-27 |
|
| 11 |
Mccall Ronald D |
Director |
121,768 |
2021-08-26 |
|
| 12 |
Bullock James |
Director |
68,647 |
2025-05-27 |
|
| 13 |
Ronald C Elkins |
Director |
64,843 |
2018-09-06 |
|
| 14 |
Stanton Marshall S. |
SVP, Clinical & Md Affair |
62,246 |
2026-03-04 |
|
| 15 |
Burbank Jeffrey H |
Director |
53,796 |
2025-05-27 |
|
| 16 |
Borgstrom Marna P |
Director |
49,088 |
2025-05-27 |
|
| 17 |
Morgan Harvey |
Director |
46,342 |
2021-08-31 |
|
| 18 |
Maney Rochelle L. |
VP, Quality |
45,632 |
2024-03-14 |
|
| 19 |
Semedo Anthony B. |
Director |
41,984 |
2025-05-27 |
|
| 20 |
Maier Dennis B |
SVP, Operations |
34,724 |
2023-06-08 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2026-03-03 |
Stanton Marshall S. |
SVP, Clinical & Md Affair |
Informative Sell |
2,149 |
$37.78 |
$81.18K |
| 2026-03-02 |
Stanton Marshall S. |
SVP, Clinical & Md Affair |
RSU Award |
21,838 |
- |
- |
| 2026-03-03 |
Davis John E |
Chief Commercial Officer |
Informative Sell |
4,573 |
$37.78 |
$172.75K |
| 2026-03-02 |
Davis John E |
Chief Commercial Officer |
RSU Award |
28,845 |
- |
- |
| 2026-03-04 |
Holloway Jean F |
SVP, General Counsel |
Informative Sell |
8,962 |
$38.00 |
$340.56K |
| 2026-03-03 |
Holloway Jean F |
SVP, General Counsel |
Informative Sell |
3,843 |
$37.78 |
$145.17K |
| 2026-03-02 |
Holloway Jean F |
SVP, General Counsel |
RSU Award |
27,795 |
- |
- |
| 2026-03-03 |
Berry Lance A |
EVP, COO, CFO & Treasurer |
Informative Sell |
6,316 |
$37.78 |
$238.59K |
| 2026-03-02 |
Berry Lance A |
EVP, COO, CFO & Treasurer |
RSU Award |
40,874 |
- |
- |
| 2026-03-03 |
Mackin James P |
President & CEO |
Informative Sell |
17,887 |
$37.78 |
$675.69K |
| 2026-03-02 |
Mackin James P |
President & CEO |
RSU Award |
116,948 |
- |
- |
| 2026-03-03 |
Horton Amy |
VP, Chief Accounting Officer |
Informative Sell |
901 |
$37.78 |
$34.04K |
| 2026-03-02 |
Horton Amy |
VP, Chief Accounting Officer |
RSU Award |
7,475 |
- |
- |
| 2026-03-02 |
Stanton Marshall S. |
SVP, Clinical & Md Affair |
Informative Sell |
1,513 |
$38.02 |
$57.53K |
| 2026-03-02 |
Davis John E |
Chief Commercial Officer |
Informative Sell |
2,784 |
$38.02 |
$105.86K |
| 2026-03-02 |
Holloway Jean F |
SVP, General Counsel |
Informative Sell |
2,183 |
$38.02 |
$83.01K |
| 2026-03-02 |
Berry Lance A |
EVP, COO, CFO & Treasurer |
Informative Sell |
5,178 |
$38.02 |
$196.89K |
| 2026-03-02 |
Mackin James P |
President & CEO |
Informative Sell |
14,911 |
$38.02 |
$566.99K |
| 2026-03-02 |
Horton Amy |
VP, Chief Accounting Officer |
Informative Sell |
641 |
$38.02 |
$24.37K |
| 2026-02-24 |
Stanton Marshall S. |
SVP, Clinical & Md Affair |
Informative Sell |
1,259 |
$35.69 |
$44.94K |
| 2026-02-23 |
Stanton Marshall S. |
SVP, Clinical & Md Affair |
Informative Sell |
2,423 |
$37.59 |
$91.08K |
| 2026-02-24 |
Davis John E |
Chief Commercial Officer |
Informative Sell |
2,075 |
$35.69 |
$74.06K |
| 2026-02-23 |
Davis John E |
Chief Commercial Officer |
Informative Sell |
3,773 |
$37.59 |
$141.82K |
| 2026-02-24 |
Holloway Jean F |
SVP, General Counsel |
Informative Sell |
1,668 |
$35.69 |
$59.54K |
| 2026-02-23 |
Holloway Jean F |
SVP, General Counsel |
Informative Sell |
3,079 |
$37.59 |
$115.73K |
